Computer-aided retraining of memory and attention in people with multiple sclerosis: a randomized, double-blind controlled trial
Introduction
The reported prevalence of cognitive impairments in people with multiple sclerosis (MS) ranges from 43% to 65% depending on study setting [1], [2]. Cognitive dysfunctions are now considered among the main factors contributing to disease-related activity and participation restrictions [1], [3], [4], and caregiver strain [5]. The functions most consistently affected are controlled attentional processing, speed of information processing, explicit anterograde memory, abstract reasoning, and executive functions [1], [2], [3], [4], [6], [7].
Pharmacological treatments [8], [9], [10], [11], [12], [13], compensatory interventions [14], and computer-aided retraining [15], [16], [17] have been investigated as remedial treatments for cognitive dysfunctions in people with MS. Computer-aided cognitive retraining programs allow unlimited repetitions of a given task and systematic changes in levels of difficulty; they can be self-administered, provide reliable records of patient performance [18], [19] and do not interfere with multi-drug therapies. The available evidence on the usefulness of computer-aided cognitive retraining in MS is however limited.
We designed a randomized, double-blind controlled multicenter trial to assess the efficacy of computer-based retraining of attention and memory in people with MS who complained of mild to moderate impairment of these functions.
Section snippets
Patients
Between January 2001 and May 2002, six Italian centers enrolled 82 people with MS. All met the diagnostic criteria of Poser et al. [20] and complained of poor attention or memory, confirmed by a score below the 80th percentile in at least two components of the Brief Repeatable Battery of Neuropsychological Tests (BRBNT) [21], [22], [23]. Participants were excluded for any one of the following: age less than 18, age over 65 years, Mini-Mental State Examination (MMSE) score <24 [24], [25],
Results
Of the 203 assessed patients, 82 were randomized. Reasons for exclusion were: refused consent (n=45); age>65 years (n=26); co-morbidities (n=15); score below 80th percentile in less than two BRBNT tests (n=22); less than primary education (n=8); exacerbation or steroid therapy (n=5); and MMSE score<24 (n=6).
Of the 82 patients enrolled, 42 were assigned to the study intervention, and 40 to the control intervention. Five randomized participants (6%) never started retraining (2 in the study and 3
Discussion
To our knowledge, this is the first double-blind randomized controlled trial to assess the efficacy of computer-aided retraining of memory and attention in people with MS. We found two previously published studies on this topic. One is a non-randomized trial on 22 outpatients [17]; the other is a randomized controlled pilot study indicating positive effects of computer-assisted memory and attention re-training [16].
We found no indication that the study treatment was superior to the control
Acknowledgements
The authors thank Alessandra Protti MD, and Raffaella Marazzi MD, for their contributions to patient recruitment. We also thank Don Ward for help with the English. The trial was supported by grant PP0798 to Solari from the National MS Society.
References (32)
- et al.
Mini-mental state: a practical method for grading the cognitive state of patients for the clinician
J. Psychiatr. Res.
(1975) - et al.
Cognitive dysfunction in multiple sclerosis: I. Frequency, patterns, and prediction
Neurology
(1991) - et al.
Cognitive function in recent-onset demyelinating diseases
Arch. Neurol.
(1986) - et al.
Screening for cognitive dysfunction in multiple sclerosis
Arch. Neurol.
(1996) - et al.
Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years
Arch. Neurol.
(2001) - et al.
Factors associated with carer strain in carers of people with multiple sclerosis
Disabil. Rehabil.
(2001) - et al.
Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI)
Neurology
(1995) - et al.
Cognitive disturbances in patients with relapsing remitting multiple sclerosis
Arch. Neurol.
(1989) - et al.
Neuropsychologic status in multiple sclerosis after treatment with Glatiramer
Arch. Neurol.
(1999) - et al.
Neuropsychological effects of interferon B-1a in relapsing multiple sclerosis
Ann. Neurol.
(2000)
Improved delayed visual reproduction test performance in MS patients receiving interferon beta-1b
Neurology
The effects of 4-aminopyridine on cognitive function in patients with multiple sclerosis
Neurology
Effect of interferon-beta-1b on cognitive functions in multiple sclerosis
Eur. Neurol.
A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments
J. Clin. Psychopharmacol.
Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis
J. Neurol. Neurosurg. Psychiatry
Effect of neuropsychological treatment in patients with multiple sclerosis
Acta Neurol. Scand.
Cited by (123)
Does cognitive training improve attention/working memory in persons with MS? A pilot study using the Cogmed Working Memory Training program
2021, Multiple Sclerosis and Related DisordersCitation Excerpt :According to a recent Cochrane review (Rosti-Otajärvi et al., 2014), investigations into cognitive rehabilitation in MS are few and pooled analyses that combined multiple studies yielded non-significant findings across various cognitive domains, including attention/working memory. Despite a number of negative findings (Solari et al., 2004; Tesar et al., 2005), more recent work in MS has showed promise in improving attention/working memory, as well as recruitment of relevant brain networks, particularly when more rigorous criteria are used (Cerasa et al., 2013; Filippi et al., 2012). Emotional and more ecological outcomes (e.g., mood, fatigue, and quality of life) are also receiving more attention in the literature, despite some conflicting findings (Rosti-Otajärvi et al., 2014; Mitolo et al., 2015).
Effects of home-based virtual reality telerehabilitation system in people with multiple sclerosis: A randomized controlled trial
2024, Journal of Telemedicine and TelecareProblems with the MetaBLIND study: An examination of data on blinding patients in trials with patient-reported outcomes
2023, Journal of Health PsychologyOccupational therapy for persons with cognitive impairments
2023, GMS German Medical ScienceFocus on neglected features of cognitive rehabilitation in MS: Setting and mode of the treatment
2022, Multiple Sclerosis Journal
- 1
Complete list of participants in CRIMS trial: Principal investigators: Alessandra Solari MD1a, Achille Motta MDa, Laura Mendozzi MDb, Eugenio Pucci MDc, Gianluigi Mancardi MDd, Marco Forni MDe, Carlo Pozzilli MDf. Other participants: Elena Barbieri PhDa, Giovanna Borriello MDf, Germana Caldora PhDf, Elisabetta Capello MDd, Domenico Caputo MDb, Elisabetta Cartechini MDc, Manuela Diverio MDe, Paola Gemignani PhDe, Giorgio Giuliani MDc, Loredana La Mantia MDa, Clara Milanese MDa, Marco Paglioritic, Carlo Serrati MDd, Alessandra Tinti MDd, Silvia Volpe PhDd, and Giusi Ferraria. a(National Neurological Institute C. Besta, Milan; bMultiple Sclerosis Unit, Fondazione Don C. Gnocchi, Milan; cNeurology Department, Macerata Hospital, Macerata; dNeurology Clinic, University of Genoa, Genoa; eFondazione Don C. Gnocchi, Marina di Massa; fDepartment of Neurological Sciences, University of Rome, Rome).